Russia Is The Most Trusted Vaccine Producer Alongside The US

Moscow, March 24, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), announces the results of a YouGov survey with 9,417 respondents from 9 countries on their vaccine preferences and country of preference in terms of vaccine production.

According to the survey, 54% of respondents who selected a country they trust to produce a vaccine, considered Russia the most trusted vaccine producer alongside the US and leaving the UK behind, when asked to choose the 3 countries they trusted the most to produce a vaccine.

Sputnik V, the world’s first registered vaccine against coronavirus, is the most recognizable one – over 7 in 10 (74%) of those surveyed have heard of the Russian vaccine. Sputnik V is also among Top-2 most preferred vaccines, just after the one produced by Pfizer/BioNTech.

The survey was conducted between February 18 and March 3 by YouGov, the leading UK-based company in market research and data analytics in Asia, Latin America, the Middle East, North Africa and Europe. Residents of India, Brazil, Mexico, the Philippines, Vietnam, Argentina, Algeria, the UAE and Serbia participated in the poll. More than 2 billion people, or over 25% of the world’s population, live in these countries.

Key findings of the poll:

  • Russia came out as the most trusted vaccine producing country, alongside the US and leaving the UK behind, when asked to choose the 3 countries they trusted the most to produce a vaccine.
  • One in three respondents (33%) among those who have made their choice, would prefer to be vaccinated with Sputnik V.
  • This is the second most-preferred vaccine after Pfizer/BioNTech vaccine (37%).


  • Sputnik V is the most recognizable vaccine: 74% of those surveyed have heard of the Russian vaccine; Pfizer/BioNTech is in second place (69%), while AstraZeneca (University of Oxford) holds third position with 60%.


  • Almost half (47%) of the respondents who have made their choice only consider a minimum vaccine efficacy level of 90% or more acceptable for their vaccination (for example, Sputnik V, which has a proven efficacy of 91.6%).
  • An overwhelming number of respondents (84%) would be willing to postpone their vaccination with a less effective vaccine of around 60%, for a vaccine with a higher efficacy of over 90%.


  • 77 percent of respondents believe that governments should provide equal access to all the different vaccines for the population and give everyone a choice which vaccine to have for vaccination.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, commented:

“Results of the YouGov survey in various parts of the world once again demonstrate the high confidence of respondents in Russia as a vaccine producer and in the Sputnik V vaccine.

Thanks to the outstanding achievements of Russian science, the Sputnik V vaccine has been saving lives around the world as it is approved for use in more than 50 countries.

The vaccine has a number of key benefits, including an efficacy of 91.6%, confirmed by the leading medical journal The Lancet, as well as a proven to be safe human adenoviral vector platform, attractive supply chain logistics and affordability, making Sputnik V one of the best vaccines in the world.”

By News784

News784 posted this article. You can send press releases and news ideas to [email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *